vs
Side-by-side financial comparison of Fresenius Medical Care AG (FMS) and IMPERIAL OIL LTD (IMO). Click either name above to swap in a different company.
IMPERIAL OIL LTD is the larger business by last-quarter revenue ($8.2B vs $5.5B, roughly 1.5× Fresenius Medical Care AG). Fresenius Medical Care AG runs the higher net margin — 7.9% vs 4.4%, a 3.6% gap on every dollar of revenue. On growth, Fresenius Medical Care AG posted the faster year-over-year revenue change (-0.3% vs -10.5%).
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives.
Imperial Oil Limited is a Canadian petroleum company. It is Canada's second-largest integrated oil company that is also occasionally known as Imperial Esso. It is majority-owned by American oil company ExxonMobil, with a 69.6% ownership stake in the company. It is a producer of crude oil, diluted bitumen, and natural gas. Imperial Oil is one of Canada's major petroleum refiners and petrochemical producers. It supplies Esso-brand service stations.
FMS vs IMO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $5.5B | $8.2B |
| Net Profit | $434.2M | $359.2M |
| Gross Margin | 27.4% | — |
| Operating Margin | 11.7% | 5.6% |
| Net Margin | 7.9% | 4.4% |
| Revenue YoY | -0.3% | -10.5% |
| Net Profit YoY | 240.4% | -59.8% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $5.5B | $8.2B | ||
| Q3 25 | — | $8.8B | ||
| Q2 25 | — | $8.2B | ||
| Q1 25 | — | $9.1B | ||
| Q4 24 | $5.5B | $9.2B | ||
| Q3 24 | — | $9.7B | ||
| Q2 24 | — | $9.8B | ||
| Q1 24 | — | $9.0B |
| Q4 25 | $434.2M | $359.2M | ||
| Q3 25 | — | $393.5M | ||
| Q2 25 | — | $692.8M | ||
| Q1 25 | — | $940.2M | ||
| Q4 24 | $127.6M | $894.3M | ||
| Q3 24 | — | $903.0M | ||
| Q2 24 | — | $827.1M | ||
| Q1 24 | — | $872.4M |
| Q4 25 | 27.4% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 25.0% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 11.7% | 5.6% | ||
| Q3 25 | — | 5.8% | ||
| Q2 25 | — | 11.1% | ||
| Q1 25 | — | 13.5% | ||
| Q4 24 | 5.1% | 12.5% | ||
| Q3 24 | — | 12.1% | ||
| Q2 24 | — | 11.1% | ||
| Q1 24 | — | 12.8% |
| Q4 25 | 7.9% | 4.4% | ||
| Q3 25 | — | 4.5% | ||
| Q2 25 | — | 8.4% | ||
| Q1 25 | — | 10.3% | ||
| Q4 24 | 2.3% | 9.7% | ||
| Q3 24 | — | 9.3% | ||
| Q2 24 | — | 8.5% | ||
| Q1 24 | — | 9.7% |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.7B | $833.7M |
| Total DebtLower is stronger | — | $2.9B |
| Stockholders' EquityBook value | $15.4B | $16.2B |
| Total Assets | $33.5B | $30.9B |
| Debt / EquityLower = less leverage | — | 0.18× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7B | $833.7M | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | — | $1.7B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | $1.3B | $714.7M | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | — | $1.5B | ||
| Q1 24 | — | $858.5M |
| Q4 25 | — | $2.9B | ||
| Q3 25 | — | $2.9B | ||
| Q2 25 | — | $2.9B | ||
| Q1 25 | — | $2.9B | ||
| Q4 24 | — | $2.9B | ||
| Q3 24 | — | $2.9B | ||
| Q2 24 | — | $2.9B | ||
| Q1 24 | — | $2.9B |
| Q4 25 | $15.4B | $16.2B | ||
| Q3 25 | — | $17.3B | ||
| Q2 25 | — | $18.2B | ||
| Q1 25 | — | $17.8B | ||
| Q4 24 | $17.0B | $17.1B | ||
| Q3 24 | — | $17.3B | ||
| Q2 24 | — | $17.5B | ||
| Q1 24 | — | $16.9B |
| Q4 25 | $33.5B | $30.9B | ||
| Q3 25 | — | $31.4B | ||
| Q2 25 | — | $32.2B | ||
| Q1 25 | — | $32.0B | ||
| Q4 24 | $36.3B | $31.3B | ||
| Q3 24 | — | $31.0B | ||
| Q2 24 | — | $32.2B | ||
| Q1 24 | — | $31.0B |
| Q4 25 | — | 0.18× | ||
| Q3 25 | — | 0.17× | ||
| Q2 25 | — | 0.16× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.17× | ||
| Q3 24 | — | 0.17× | ||
| Q2 24 | — | 0.17× | ||
| Q1 24 | — | 0.17× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.9B | $1.4B |
| Free Cash FlowOCF − Capex | — | $938.8M |
| FCF MarginFCF / Revenue | — | 11.4% |
| Capex IntensityCapex / Revenue | — | 5.6% |
| Cash ConversionOCF / Net Profit | 6.67× | 3.90× |
| TTM Free Cash FlowTrailing 4 quarters | — | $3.4B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.9B | $1.4B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | $2.6B | $1.3B | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | — | $1.2B | ||
| Q1 24 | — | $785.5M |
| Q4 25 | — | $938.8M | ||
| Q3 25 | — | $944.6M | ||
| Q2 25 | — | $725.6M | ||
| Q1 25 | — | $824.2M | ||
| Q4 24 | — | $997.2M | ||
| Q3 24 | — | $730.7M | ||
| Q2 24 | — | $852.6M | ||
| Q1 24 | — | $422.7M |
| Q4 25 | — | 11.4% | ||
| Q3 25 | — | 10.7% | ||
| Q2 25 | — | 8.8% | ||
| Q1 25 | — | 9.0% | ||
| Q4 24 | — | 10.8% | ||
| Q3 24 | — | 7.5% | ||
| Q2 24 | — | 8.7% | ||
| Q1 24 | — | 4.7% |
| Q4 25 | — | 5.6% | ||
| Q3 25 | — | 4.2% | ||
| Q2 25 | — | 4.2% | ||
| Q1 25 | — | 3.2% | ||
| Q4 24 | — | 3.4% | ||
| Q3 24 | — | 3.7% | ||
| Q2 24 | — | 3.4% | ||
| Q1 24 | — | 4.0% |
| Q4 25 | 6.67× | 3.90× | ||
| Q3 25 | — | 3.34× | ||
| Q2 25 | — | 1.54× | ||
| Q1 25 | — | 1.19× | ||
| Q4 24 | 20.20× | 1.46× | ||
| Q3 24 | — | 1.20× | ||
| Q2 24 | — | 1.44× | ||
| Q1 24 | — | 0.90× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
